Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: RockyBalboa who wrote (11833)	5/2/2003 9:09:02 AM
From: EVENT HORIZON III	Respond to of 48461

Hiya Bubba, Thanks...I'm a Technicals freak too. However ya really gotta understand the underlying factors. The company & the way they did the funding. They drove the stock down to get cheap shares at a fixed level of .79. Certain Holders are just businessmen. They are just in it to flip the stock as quickly as possible. Understand there is little resistance. If you are familiar with the use of creating a short covering rally to enhance an exit strategy then you understand. Look at ENMD. They recently did a funding too. Similar scenario. It popped much like I expect ARDM too. Just the nature of the beast. Thanks for the technical take. This stock is not a recommend based on some sort of uptrend. Its based on factors like VION ENMD CRIS & GERN. One of the few ways to create a cash infusion into R&D. If anything. If you trade stocks like the above on days of pops then at least put this one on your Volume & News watch lists... TICKTOCKTICKTOCK Enjoy Jeff

To: RockyBalboa who wrote (11833)	5/14/2003 10:14:16 PM
From: EVENT HORIZON III	Respond to of 48461

Hey Check it out. First read your last post to me. Understand ARDM will run. stockcharts.com[m,a]daclyyay[dd][pc20!b13][vc60][iUf!Lc20]&pref=G Like I said bottomed & the uptrend is becoming more pronounced. Jeff

To: RockyBalboa who wrote (11833)	5/26/2003 5:36:01 PM
From: EVENT HORIZON III	Read Replies (2) \| Respond to of 48461

Hi Midland, At $1.75 ARDM has a lot of room to the upside. Rarely if ever do companies stocks not appreciate in late stage Clinical Advances. I expect appreciation through the fall. 1. The company is expected to announce a couple new partners. 2. Additional clinical data { which will be safe { the decision to do Phase Three is already made hence this data should prove convincing & supportative ) & could have very good upside impact } 3. The recent acquisition was speculative value additive & should boost any momentum. 4. The company has two unannounced partnered targets that have upside when light is shed on their progress. Technicals on ARDM are very supportive of further nearterm upside moves. finance.yahoo.com. Notice the INCREASED volume at ARDM & CONTINUED ACCUMULATION finance.yahoo.com. I'm expecting a BREAKOUT above $1.80 over the next two weeks & the near term price target is $2.50. stockcharts.com A followup Price Target of $3.50 is expected by July based on near term expectations... There is little reason to not expect $3.50 min to $6 max as a target going forward... Jeff